Solvay Ventures veteran Alexandre Ouimet-Storrs has joined Mercia alumna Nicola Broughton to form a medical cannabis-focused investment firm.
Two of Europe’s most experienced venture investors have joined forces to set up an investment firm called Óskare Capital to targeting medical cannabis product developers from seed to patient stage.
Nicola Broughton and Alexandre Ouimet-Storrs are the co-founders and managing partners at Óskare Capital, which launched its first fund yesterday. Its first investment was in Octarine Bio, a developer of cannabinoid and psilocybin derivatives.
Ouimet-Storrs was previously managing director for Europe at…
